1887

oa SA Pharmaceutical Journal - New drug focus : drug info

 

Abstract

FosavanceTM contains the bisphosphonate, alendronate in combination with vitamin D in the form of cholecalciferol. The combination is indicated for the treatment of postmenopausal osteoporosis to reduce the risk of fractures, including those of the hip and spine.

Loading

Article metrics loading...

/content/mp_sapj/75/1/EJC81839
2008-01-01
2016-12-02
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error